Role of Sclerotherapy in Treating Oral Vascular Malformations in Hereditary Hemorrhagic Telangiectasia
Otolaryngology–Head and Neck Surgery · 2026
DOI: 10.1002/ohn.70088 ↗At a glance
Journal article in Otolaryngology–Head and Neck Surgery, 2026. Written by Avraham E Adelman and 7 co-authors. Institution: Department of Otolaryngology-Head & Neck Surgery, University of Florida, Gainesville, Florida, USA. Major MEDLINE topics: Telangiectasia, Hereditary Hemorrhagic, Sclerotherapy, Vascular Malformations, Mouth Diseases. 5 references.
Abstract (original language)
Oral telangiectasias in hereditary hemorrhagic telangiectasia (HHT) can significantly impair quality of life. While sclerotherapy is an established treatment for HHT‐related epistaxis, it is rarely used for oral telangiectasias. We retrospectively reviewed HHT patients who underwent oral sclerotherapy between 2021 and 2024 at a tertiary academic center. Eleven patients (64% female, mean age 61.3 years, 82% ACVRL1 genotype) underwent sclerotherapy using a 1:4 mixture of 3% sodium tetradecyl sulfate and air. Lesions treated included the lip (36%), tongue (36%), hard palate (18%), and gingiva (9%). Presenting symptoms included oral bleeding with eating and dietary limitations. Adverse effects included transient lip swelling (n = 2) and tongue burning (n = 1). At an average follow‐up of 6 months, 10/11 patients with follow‐up data had complete symptomatic and clinical resolution. Our findings suggest that oral sclerotherapy is a safe, effective, and minimally invasive treatment for HHT‐related oral bleeding that clinicians should consider.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Otolaryngology-Head & Neck Surgery, University of Florida, Gainesville, Florida, USA.
- Division of Pulmonary, Critical Care & Sleep Medicine, Department of Medicine, University of Florida, Gainesville, Florida, USA.
ORCID profiles: Avraham E Adelman
Cite
APA
Adelman, A. E., Joshi, A., Gallo, K., Prosser, A., Mathavan, A., Mathavan, A., Ataya, A., & Justice, J. (2026). Role of Sclerotherapy in Treating Oral Vascular Malformations in Hereditary Hemorrhagic Telangiectasia. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.70088
Vancouver
Adelman AE, Joshi A, Gallo K, Prosser A, Mathavan A, Mathavan A, et al. Role of Sclerotherapy in Treating Oral Vascular Malformations in Hereditary Hemorrhagic Telangiectasia. Otolaryngology–Head and Neck Surgery. 2026. doi:10.1002/ohn.70088
BibTeX
@article{Adelman2026,
author = {Adelman, Avraham E and Joshi, Advay and Gallo, Kimberly and Prosser, Aaron and Mathavan, Akash and Mathavan, Akshay and Ataya, Ali and Justice, Jeb},
title = {Role of Sclerotherapy in Treating Oral Vascular Malformations in Hereditary Hemorrhagic Telangiectasia},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2026},
doi = {10.1002/ohn.70088}
}
EUVIMED